drugset / Trial / NCT04760769
Open-label Trial in Parkinson's Disease (PD)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Parkinson's Disease.
Timeline
- Start
- 2021-02-24
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tavapadon | Small molecule | 5 mg | Oral |
| Subject | Tavapadon | Small molecule | 15 mg | Oral |